|Articles|October 1, 2001
VISX, Medjet share research on waterjet, might unite
Santa Clara, CA-VISX Inc. will pay Medjet Inc. to pursue new ophthalmictechnologies and products in exchange for a 1-year option to acquire alloutstanding Medjet common stock in a merger transaction that would pay $2cash per share.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye
2
Port Delivery System Therapies in Retinal Vascular Diseases
3
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
4
Safety Considerations in Retinal Vascular Diseases
5


















